Profound Medical Partners With FMS to Bring Cutting-Edge Uterus and Prostate Treatments to Saudi Arabia
Profound Medical Corp. has inked an exclusive agreement with Al Faisaliah Medical Systems Co. (FMS) for the distribution and supply of its innovative TULSA-PRO and Sonalleve technologies in Saudi Arabia. This collaboration brings advanced treatment options for prostate and uterine diseases to the Kingdom.
FMS, a subsidiary of Al Faisaliah Group, one of Saudi Arabia's leading business conglomerates, will distribute Profound's technologies. TULSA-PRO, designed for prostate disease treatment, has already assisted over 4,000 men worldwide. It employs MRI guidance and directional ultrasound for precise heating of prostate tissue. Meanwhile, Sonalleve treats uterine fibroids and adenomyosis using MR imaging and focused ultrasound, with over 4,000 women benefiting globally.
Profound is expanding its reach, deploying a direct sales team in North America and partnering strategically elsewhere. FMS, established in 1973, is a major healthcare equipment provider in Saudi Arabia, offering state-of-the-art medical technologies across various specialties and owning specialized medical facilities.
Through this partnership, Profound's innovative technologies will bolster healthcare services in Saudi Arabia. FMS's extensive network and expertise ensure these advanced treatments reach patients across the Kingdom, enhancing prostate and uterine health.
